肝源性糖尿病171例临床分析  

Clinical Analysis of 171 Cases of Hepatic Diabetes

作　　者：马春涛[1] 骆成林[1] 

机构地区：[1]江苏省苏州市相城人民医院消化内科,江苏苏州215131

出　　处：《中国继续医学教育》2017年第24期95-97,共3页China Continuing Medical Education

基　　金：江苏省苏州市"科教兴卫"青年科技项目(kjxw2014057)

摘　　要：目的探讨血糖在改善肝源性糖尿病的肝功能中的意义及价值。方法完整收集2011年10月—2016年7月本院171例HD的临床资料,对HD患者按肝功能分级分为A、B、C级,比较各级在血糖控制达标前后的肝功能变化及发生肝性脑病的次数。结果血糖控制达标12周后,肝功能A级人数较治疗前明显增加,B级明显减少,P<0.05,差异有统计学意义,C级人数治疗前后无明显变化,P>0.05;肝性脑病较治疗减少7次,P<0.05,两者间差异有统计学意义。结论血糖控制可改善肝源性糖尿病患者的肝功能及减少肝性脑病发生的几率,提高生存质量。Objective To investigate the significance and value of blood glucose in improving liver function in patients with hepatic diabetes. Method From October 2011 to July 2016, 171 cases with HD, according to the classifcation of liver function were divided into A, B, C, the number of levels in the comparison of changes of liver function before and after standard glucose control and the occurrence of hepatic encephalopathy. Results After 12 weeks of blood glucose control, the number of liver function class a increased significantly, and the level of B decreased significantly, P 〈 0.05, the difference was statistically significant, there was no signifcant change in the number of C before and after treatment, P 〉 0.05; Hepatic encephalopathy was reduced by 7 times, P 〈 0.05, and the difference was statistically significant. Conclusion Glycemic control can improve the liver function and reduce the incidence of hepatic encephalopathy and improve the quality of life in patients with hepatic diabetes.

关 键 词：肝源性糖尿病 肝功能 血糖 

分 类 号：R587[医药卫生—内分泌]